Sample | MDD (n = 39) | MDE/BD (n = 33) | MDE/BPD (n = 23) | Total sample (n = 95) | ||||||
---|---|---|---|---|---|---|---|---|---|---|
mean / n | sd / % | mean / n | sd / % | mean / n | sd / % | mean / n | sd / % | p | ||
Age | 31.41 | 10.29 | 32.79 | 9.62 | 27.98 | 7.10 | 31.06 | 9.46 | 0.167 | |
Sex | Female | 21 | 53.8% | 25 | 75.8% | 16 | 69.6% | 62 | 65.3% | 0.168 |
Male | 18 | 46.2% | 8 | 24.2% | 7 | 30.4% | 33 | 34.7% | ||
BPD | 0 | 0.0% | 2 | 6.1% | 23 | 100.0% | 25 | 26.3% | < 0.001 | |
Bipolar | 0 | 0.0% | 33 | 100.0% | 6 | 26.1% | 39 | 41.1% | < 0.001 | |
Type I | 0 | 0.0% | 8 | 24.2% | 0 | 0.0% | 8 | 8.4% | ||
Type II | 0 | 0.0% | 25 | 75.8% | 6 | 26.1% | 31 | 33.7% | ||
MDE features | Melancholic | 12 | 30.8% | 12 | 36.4% | 10 | 43.5% | 34 | 35.8% | 0.585 |
Atypical | 9 | 23.1% | 3 | 9.1% | 6 | 26.1% | 18 | 18.9% | 0.196 | |
Baseline | MADRS | 23.62 | 5.98 | 22.21 | 7.05 | 21.52 | 6.35 | 22.62 | 6.45 | 0.426 |
BDI II | 27.45 | 9.91 | 30.44 | 11.78 | 32.94 | 9.54 | 29.88 | 10.63 | 0.215 | |
OASIS | 11.69 | 3.33 | 12.85 | 3.73 | 12.22 | 5.08 | 12.22 | 3.94 | 0.467 | |
BPDSI | 14.81 | 7.33 | 16.65 | 6.75 | 25.60 | 8.42 | 17.48 | 8.29 | < 0.001 | |
Follow-up | MADRS | 15.43 | 9.71 | 12.96 | 12.00 | 16.50 | 4.77 | 14.79 | 9.86 | 0.455 |
BDI II | 19.32 | 12.11 | 19.04 | 16.58 | 26.27 | 10.85 | 20.54 | 13.72 | 0.201 | |
OASIS | 9.16 | 4.48 | 8.44 | 5.33 | 10.40 | 4.42 | 9.15 | 4.76 | 0.499 | |
BPDSI | 11.61 | 8.33 | 11.88 | 7.13 | 19.03 | 7.85 | 13.17 | 8.28 | 0.005 | |
Correlations | MADRS | 0.48 | 0.32 | 0.21 | 0.36 | |||||
BDI II | 0.45 | 0.68 | 0.39 | 0.53 | ||||||
OASIS | 0.44 | 0.52 | 0.55 | 0.47 | ||||||
BPDSI | 0.66 | 0.48 | 0.63 | 0.69 |